Long-Lasting Frameshifted Protein Products from Covid ‘Vaccination’

Written by Dr Peter McCullough MD, MPH on May 31, 2024. Posted in Current News

No one could have predicted what would happen with mass injection of synthetic, fully pseudouridinated mRNA coding for the potentially lethal Wuhan SARS-CoV-2 Spike protein all loaded on injected, widely circulatory lipid nanoparticles

To a lay person, just the description of this product sounds like a bad idea from the outset.

I sat down with biochemist Dr. Laszlo G. Boros, MD to discuss his recent paper on the production of frameshifted polypeptides as ribosomes read the synthetic mRNA and come across the non-human code.

He believes there is sufficient molecular rationale and emerging data suggest the body may make a dozen or more proteins beyond the Wuhan Spike. This leads to further recognition of cells as non-self and auto-immunity.

Given the bizarre and never experienced array of internally produced proteins, Boros believes this mechanism in part could lead to oncogenesis or new cancerous cells.

Here is a brief autobiography from Boros:

“I am a retired (2021) Professor of Pediatrics at the University of California Los Angeles (UCLA) School of Medicine, the Co-Director of the Stable Isotope Research Laboratory at the Lundquist Institute for Biomedical Innovations (LUNDQUIST) and Investigator at the Clinical and Translational Research Institute at the Harbor-UCLA Medical Center with a primary focus on studying cancer cell metabolism with the use of a specifically designed 13C-glucose and deuterium tracers along with mass spectroscopy.

I am the inventor of the Human Deutenome Project and Deugnostics as deuterium based medical diagnostics including imaging and laboratory methods in order to map the distribution of deuterium in the human body with structural and functional interpretations as it relates to disease and health.

Born and educated in Hungary, my medical background includes three years of gastroenterology and pancreatology, focusing on chronic pancreatitis and pancreatic cancer. I spent two years as a visiting scholar in Essen, Germany, studying various animal models of chronic pancreatitis.

In 1990, I moved to Columbus, Ohio, and joined the history-making laboratory of Drs. Zollinger and Ellison, who discovered hormonal regulatory mechanisms involved in pancreatic cancer growth where I trained in biochemistry, diagnostics and integrative treatments.

​In 1995 I became the lead investigator to clinically apply 13C and 2H (deuterium) based stable isotope technologies to study diabetes and cancer cell growth in vitro, in animal models and human cohorts at UCLA.

am an expert in using metabolic profiling and mitochondrial nanomechanics to the further understanding of particularly aggressive cancers. I also participate in research projects targeting population metabolic disorders, such as diabetes and obesity, and I am involved in discovering the underlying mechanisms of rare metabolic disorders arising from genetic mutations affecting vitamin transport.

I am an internationally recognized expert of metabolic water biochemistry as well as deuterium mediated kinetic isotopic effects in health and disease, which are translational fields of Deutenomics in medicine.

My most recent studies target deupletion and deuposition related mechanisms as the result of intra-cellular hydrophobic lipid membrane nanoconfinements via the Quantum Destabilization of Protons in metabolic water.

Boros is the recipient, among others, of the:

• C. Williams Hall Outstanding Publication Award from the Academy of Surgical Research of the USA (1997),
• the Richard E. Weitzman Memorial Research Award from the University of California (2001),
• the Excellence in Clinical Research Award from the General Clinical Research Center at the Harbor-UCLA Medical Center (2004),
• Public Health Impact Investigator Award of the United States Food and Drug Administration (2011)
• and received a Best Publication Award from the Metabolomics Society and Springer Nature publisher (2014).”

Please enjoy this highly technical interview (on the source document – Ed) to get the details which I am sure will be of high interest to those with scientific backgrounds.

See more here substack.com

Please Donate Below To Support Our Ongoing Work To Expose The Lies About Covid 19

PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX. 

Trackback from your site.